Tower Research Capital LLC (Trc) Intellia Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 32,137 shares of NTLA stock, worth $349,007. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,137
Previous 8,148
294.42%
Holding current value
$349,007
Previous $95,000
140.0%
% of portfolio
0.01%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding NTLA
# of Institutions
341Shares Held
95.7MCall Options Held
1.29MPut Options Held
1.09M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$141 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$118 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$104 Million0.0% of portfolio
-
State Street Corp Boston, MA4.51MShares$49 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.8MShares$41.3 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $825M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...